TY - JOUR
T1 - CEFTRIAXONE VERSUS AMPICILLIN AND CHLORAMPHENICOL FOR TREATMENT OF BACTERIAL MENINGITIS IN CHILDREN
AU - Del Rio, MariaDeLosA
AU - Shelton, Sharon
AU - Chrane, Dale
AU - Mccracken, GeorgeH
AU - Nelson, JohnD
PY - 1983/6/4
Y1 - 1983/6/4
N2 - 78 patients with bacterial meningitis were evaluated in a prospective, randomised study comparing twice-daily ceftriaxone as single-drug therapy with ampicillin and chloramphenicol given every 6 h. The groups were comparable in age, sex, days of illness before admission, and bacterial colony counts in cerebrospinal fluid (CSF). The pathogens were Haemophilus influenzae type b (54 cases), streptococci (9 cases), meningococci (9 cases), and unknown (6 cases). In 40 CSF specimens obtained 4-12 h after initiation of therapy, cultures were negative in 57% of the ceftriaxone patients and in 42% of the others. The mean falls in the CSF bacterial colony counts were 4.7 and 5.0 log10 colony-forming units/ml, respectively. Mean bactericidal activity in CSF was significantly greater in the ceftriaxone than in the conventional treatment group at the beginning and end of therapy. There were no significant differences in clinical responses or in frequency of complications, except for mild diarrhoea, which occurred in 16 ceftriaxone patients and in 8 in the other group (p<0·05).
AB - 78 patients with bacterial meningitis were evaluated in a prospective, randomised study comparing twice-daily ceftriaxone as single-drug therapy with ampicillin and chloramphenicol given every 6 h. The groups were comparable in age, sex, days of illness before admission, and bacterial colony counts in cerebrospinal fluid (CSF). The pathogens were Haemophilus influenzae type b (54 cases), streptococci (9 cases), meningococci (9 cases), and unknown (6 cases). In 40 CSF specimens obtained 4-12 h after initiation of therapy, cultures were negative in 57% of the ceftriaxone patients and in 42% of the others. The mean falls in the CSF bacterial colony counts were 4.7 and 5.0 log10 colony-forming units/ml, respectively. Mean bactericidal activity in CSF was significantly greater in the ceftriaxone than in the conventional treatment group at the beginning and end of therapy. There were no significant differences in clinical responses or in frequency of complications, except for mild diarrhoea, which occurred in 16 ceftriaxone patients and in 8 in the other group (p<0·05).
UR - http://www.scopus.com/inward/record.url?scp=0020530028&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0020530028&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(83)92696-X
DO - 10.1016/S0140-6736(83)92696-X
M3 - Article
C2 - 6134039
AN - SCOPUS:0020530028
SN - 0140-6736
VL - 321
SP - 1241
EP - 1244
JO - The Lancet
JF - The Lancet
IS - 8336
ER -